Uncategorized

If at first …..

There are times in this wacky world of ours when you sit back scratch your head and wonder what the heck are these people thinking. Well  more than six years after acquiring Medingo Roche is finally getting set to launch the Solo insulin pump. According to a company issued press release; “Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received CE Mark for its Accu Chek® Solo micropump...

Words matter

Take a look at the two following statements from the Lilly earnings press release; “For the second quarter of 2018, worldwide Humalog revenue increased 13 percent compared with the second quarter of 2017, to $769.8 million. Revenue in the U.S. increased 19 percent, to $464.5 million driven by higher realized prices due to changes in estimates to rebates and discounts and changes in payer segment mix, and, to a lesser extent,...

Might as well start now

Ironically as Abbott reported earnings news comes from across the pond that Nemaura Medical is about to jump into the CGM pool. Per a story posted on the MassDevice web site; “Nemaura Medical (NSDQ: NMRD) said today that it placed an initial order to its UK-based contract manufacturer for 12,500 rechargeable transmitters, designed as part of the company’s sugarBeat glucose monitoring systems.” Never mind whether the sugarBeat works or not, never mind...

Any money being made here?

There is little doubt that Abbott who reported earnings this morning is selling FreeStyle Libre’s. As per today’s press release; “In Diabetes Care, where sales increased 39.8 percent on a reported basis and 33.6 percent on an organic basis, growth was led by continued rapid market uptake of FreeStyle® Libre, Abbott's revolutionary sensor-based continuous glucose monitoring (CGM) system, which removes the need for routine fingersticks1 for people with diabetes.” Before we go...

Nuts to that

There is a reason we like to enjoy our summer here in Chicago and not just because the weather is great. A big reason is that summer time is traditionally time for vacations or in our case doing triathlon’s. But another reason we like summer is that it brings out the wacky in our world. Just today we learned that JNJ has sold Calibra to CeQur which is kind of interesting...

Is diabetes becoming the have’s and have not’s

While the toy makers play with their toys and the drug companies battle with payors, an interesting dynamic seems to be developing that’s worth exploring. Has diabetes become a case of the have’s and have nots. Has scale become so critical that it by itself trumps other concerns? Will this stifle innovation as companies grapple with increasing demands for lower prices? Can they successfully navigate the treacherous waters of satisfying...

Here we go yet again

There are certain things we just love about our wacky world for as we continually state anything can happen and usually does. This is why we weren’t surprised when we learned that Sensile Medical who just signed a deal with OnDuo, the Sanofi Google joint venture, was acquired. Per a company issued press release; “Gerresheimer will acquire the Swiss technology company Sensile Medical and thereby significantly expand its business offerings. For...

Let’s take this show on the road

Before we get onto business we’d like to issue an apology to our friends across the pond as several readers noted England did win the World Cup back in 1966. Unfortunately, the Three Lions we’re unable to get past pesky Croatia yesterday falling 2-1 in extra time. Up next for pesky Croatia is France in Sunday’s final. Nothing against Le Bleu but our hearts are with pesky Croatia to bring...

Le Bleu

Yes, the champagne is popping and the chardonnay is flowing as the French national soccer team, known as Le Bleu, defeated Belgium yesterday to advance to the finals of the World Cup. Although we haven’t spoken with any of our wine drinking friends you can bet the folks at Sanofi are happier than pigs in slop. For not only has Le Bleu reached the pinnacle of the soccer world the...

Enjoy it while it lasts

This morning Medtronic and UnitedHealthCare announced first year results from their value-based relationship. Per a joint press release; “Results from an analysis of over 6,000 members with diabetes on Medtronic MiniMed(TM) 630G and previous generation insulin pumps demonstrated 27 percent fewer preventable hospital admissions compared to plan participants who are on multiple daily injections of insulin (MDI). The analysis included a mix of members utilizing both standalone insulin pumps and pumps...